Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: Long-term followup of a prospective study

Journal of Urology

Volumn 159, Issue 1, 1998, Pages 95-99

  Solsona, E ^a   Iborra, I ^a   Ricos J V ^a   Monros J L ^a   Casanova, J ^a   Calabuig, C ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

Author keywords

BCG vaccine; Bladder neoplasms; Cystectomy

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER MUSCLE; CANCER IMMUNOTHERAPY; CANCER INFILTRATION; CANCER INVASION; CANCER STAGING; CARCINOMA IN SITU; CLINICAL TRIAL; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTRAVESICAL DRUG ADMINISTRATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; TRANSURETHRAL RESECTION; TUMOR BIOPSY;

EID: 0031986427     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64022-9     Document Type: Article

References (13)

1. Barnes, R. W., Dick, A. L., Hadley, H. L. and Johnston, O. L.: Survival following transurethral resection of bladder carcinoma. Cancer Res., 37: 1895, 1977.
2. Henry K., Miller, J., Mori, M., Loening, S. and Fallon, B.: Comparison of transurethral resection to radical therapies for stage B bladder tumors. J. Urol., 140: 964, 1988.
3. Milner, W. A.: The role of conservative surgery in the treatment of bladder tumours. Brit. J. Urol., 26: 375, 1954.
4. O'Flynn, J. D., Smith, J. D. and Hanson, J. S.: Transurethral resection for the assessment and treatment of vesical neoplasms. A review of 800 consecutive cases. Eur. Urol., 1: 38, 1975.
5. Herr, H. W.: Conservative treatment of muscle-infiltrating bladder cancer prospective experience. J. Urol., 138: 1162, 1987.
6. Solsona, E., Iborra, I., Ricós, J. V., Monrós, J. L. and Dumont, R.: Feasibility of transurethral resection for muscle-infiltrating carcinoma of the bladder: prospective study. J. Urol., 147: 1513, 1992.
7. Solsona, E., Iborra, I., Ricós, J. V., Monrós, J. L., Dumont, R. and Casanova, J. L.: Feasibility of transurethral resection for muscle-infiltrating carcinoma of the bladder: prospective study, after 5 year of minimum follow-up. Proceedings of XI Congress of European Association of Urology, abstract 428, p. 225, 1994.
8. Solsona, E., Iborra, I., Ricós, J. V., Monrós, J. L., Dumont, R., Casanova, J. L. and Calabuig, C.: Carcinoma in situ associated with superficial bladder tumor. Eur. Urol., 19: 93, 1991.
9. Brossman, S. A.: The use of bacillus Calmette-Guérin in the therapy of bladder carcinoma in situ. J. Urol., 134: 36, 1985.
10. deKernion, J. B., Huang, M. Y., Linder, A., Smith, R. B. and Kaufman, J. J.: The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guérin. J. Urol., 133: 598, 1985.
11. Herr, H. W., Pinsky, C. M., Whitmore, W. F., Sogani, P. C., Oettgen, H. F. and Melamed, M. R.: Long-term effect of intravesical bacillus Calmette-Guérin on flat carcinoma in situ of the bladder. J. Urol., 135: 265, 1986.
12. Steg, A., Leleu, C., Boccon-Gibod, L. and Debre, B.: Traitement des tumeurs superficielles et des carcinoma in situ de vessie par BCG-thérapie intravésicale. Ann. Urol., 20: 26, 1986.
13. Shipley, W. U., Rose, A. M., Perrone, T. P., Mannix, C. M., Heney, N. M. and Prout, G. J.: Full-dose Irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J. Urol., 134: 697, 1985.